Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs041190061Active, not recruiting
Open-label, single-arm trial of antithymocyte globulin rabbit, tacrolimus, methotrexate and prednisolone in Acute Leukaemia, sponsored by Kaneka. Primary endpoint: 2-year event-free survival. Started Oct 2019; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs041190061.